MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Pharmaceutical Development and Clinical Trials (Facts & Figures)
2018: The top 15 pharma companies by 2017 revenue
Amgen Inc. (NASDAQ:AMGN)
Organization & Developments: Amgen
*Amgen: Brands
Neulasta-infection deterrent for chemotherapy (28% 2005 Growth)
$577m (2005)
Parents
Neulasta-infection deterrent for chemotherapy (28% 2005 Growth)